You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Drug Formulary
About the Drug Formulary Email Drug Formulary Team

Funded Evidence-Informed Regimens

Drug and regimen monographs and information sheets for patients provide information on dosing and administering cancer treatment protocols. They are for general reference and are not meant to replace prescribing information or physician recommendations.

If you have questions about ST-QBP funding on our website, please visit our Frequently Asked Questions page.

Find enhanced Regimen Patient Information Sheets, created in collaboration with patient and family advisors.

Regimens

Filtered By:
97 Items
Cancer Type: Gynecologic, Germ Cell     
Intent: Adjuvant
Drugs Used:
bleomycin,
CISplatin,
etoposide
... Show more tags
Quick Link(s):
Regimen Monograph
May 2019
Cancer Type: Gynecologic, Germ Cell     
Intent: Curative
Drugs Used:
PACLitaxel,
bleomycin,
etoposide,
CISplatin
... Show more tags
Quick Link(s):
Regimen Monograph
May 2019
Cancer Type: Gynecologic, Ovary     
Intent: Palliative
Funding:
New Drug Funding Program
    Bevacizumab (Biosimilar) with Paclitaxel and Carboplatin - Front-line Treatment (Previously Untreated) Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
... Show more tags
Drugs Used:
bevacizumab (Unfunded)
... Show more tags
Quick Link(s):
Regimen Monograph
Oct 2019
Cancer Type: Breast, Gastrointestinal, Colorectal, Esophagus, Gastric / Stomach, Hepatobiliary / Liver / Bile Duct, Pancreas, Genitourinary, Bladder / Urothelial, Prostate, Gynecologic, Cervix, Endometrial, Ovary, Lung, Small Cell     
Intent: Palliative
Drugs Used:
cyclophosphamide,
DOXOrubicin,
vinCRIStine
... Show more tags
Quick Link(s):
Regimen Monograph
Jul 2019
Cancer Type: Gynecologic, Cervix, Endometrial, Ovary, Vulva     
Intent: Adjuvant, Palliative
Drugs Used:
CISplatin
... Show more tags
Quick Link(s):
Regimen Monograph
Updated
Dec 2019
Cancer Type: Gynecologic, Endometrial     
Intent: Adjuvant
Drugs Used:
CISplatin
... Show more tags
Quick Link(s):
Regimen Monograph
May 2019
Cancer Type: Gynecologic, Vulva     
Intent: Neoadjuvant, Palliative
Drugs Used:
CISplatin
... Show more tags
Quick Link(s):
Regimen Monograph
Oct 2017
Cancer Type: Gynecologic, Cervix     
Intent: Curative, Palliative
Drugs Used:
CISplatin
... Show more tags
Quick Link(s):
Regimen Monograph
Updated
Nov 2019
Cancer Type: Gynecologic, Uterine Sarcoma, Sarcoma, Uterine     
Intent: Adjuvant, Palliative
Drugs Used:
CISplatin,
DOXOrubicin
... Show more tags
Quick Link(s):
Regimen Monograph
May 2019
Cancer Type: Gynecologic, Endometrial     
Intent: Adjuvant, Palliative
Drugs Used:
CISplatin,
DOXOrubicin
... Show more tags
Quick Link(s):
Regimen Monograph
May 2019
Cancer Type: Breast, Central Nervous System, Gastrointestinal, Colorectal, Esophagus, Gastric / Stomach, Hepatobiliary / Liver / Bile Duct, Pancreas, Genitourinary, Bladder / Urothelial, Prostate, Gynecologic, Cervix, Endometrial, Ovary, Head and Neck, Lung, Small Cell     
Intent: Palliative
Drugs Used:
CISplatin,
etoposide
... Show more tags
Quick Link(s):
Regimen Monograph
Mar 2018
Cancer Type: Breast, Gastrointestinal, Colorectal, Esophagus, Gastric / Stomach, Hepatobiliary / Liver / Bile Duct, Pancreas, Genitourinary, Bladder / Urothelial, Prostate, Gynecologic, Cervix, Endometrial, Ovary, Head and Neck, Lung, Small Cell     
Intent: Adjuvant
Drugs Used:
CISplatin,
etoposide
... Show more tags
Quick Link(s):
Regimen Monograph
Aug 2018